Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines

Xin Liu; Xiu-Jie Wang

doi:10.1016/j.jgg.2020.02.001

Volume 47 Issue 2

Feb. 2020

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2020 > 47(2): 119-121

PDF( 783 KB)

Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines

doi: 10.1016/j.jgg.2020.02.001

Xin Liu¹,
Xiu-Jie Wang^{2, 3, 4}

1
Key Laboratory of Genetic Network Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, 100101, China
2
Key Laboratory of Genetic Network Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, 100101, China
3
University of Chinese Academy of Sciences, Beijing, 100049, China
4
Innovation Academy for Seed Design, Chinese Academy of Sciences, Beijing, 100101, China

More Information

Corresponding author: E-mail address: xjwang@genetics.ac.cn (Xiu-Jie Wang)
Publish Date: 2020-02-25

Abstract

FullText(HTML)

References(13)

References

[1]	Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J.R., and Hilgenfeld, R., 2003. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science. 300, 1763-1767.
[2]	Cui, J., Li, F., and Shi, Z.L., 2019. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 17, 181-192.
[3]	Dhama, K., Pawaiya, R., Chakraborty, S., Tiwari, R., M, S., and Verma, A., 2014. Coronavirus infection in equines: a review. Asian J. Anim. Vet. Adv. 9, 164-176.
[4]	Gorbalenya, A.E., Donchenko, A.P., Blinov, V.M., and Koonin, E.V., 1989. Cysteine proteases of positive strand RNA viruses and chymotrypsin-like serine proteases. A distinct protein superfamily with a common structural fold. FEBS Lett. 243, 103-114.
[5]	Hui, D.S., E, I.A., Madani, T.A., Ntoumi, F., Kock, R., Dar, O., Ippolito, G., McHugh, T.D., Memish, Z.A., Drosten, C., Zumla, A., and Petersen, E., 2020. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect Dis. 91, 264-266.
[6]	Lai, M.M.C., Holmes, K.V., 2001. Coronaviridae: the viruses and their replication, in: Knipe, D.M. and Howley, P.M. (Eds.), Fields virology. Lippincott Williams & Wilkins, Philadelphia, pp. 1163-1179.
[7]	Lu, H., Stratton, C.W., and Tang, Y.W., 2020. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. J. Med. Virol. DOI: 10.1002/jmv.25678.
[8]	Masters, P.S., Perlman, S., 2013. Coronaviridae, in: Knipe, D.M. and Howley, P.M. (Eds.), Fields virology. Lippincott Williams & Wilkins, Philadelphia, pp. 825-858.
[9]	Nukoolkarn, V., Lee, V.S., Malaisree, M., Aruksakulwong, O., and Hannongbua, S., 2008. Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors. J. Theor. Biol. 254, 861-867.
[10]	Regenmortel, M.H.V. van, Fauquet, C.M., Bishop, D.H.L., Carstens, E.B., Estes, M. K., Lemon, S.M., Maniloff, J., Mayo, M.A., McGeoch, D.J., Pringle, C.R., Wickner, R.B., 2000. Coronaviridae, in: Regenmortel, M.H.V. van, Fauquet, C.M., Bishop, D.H.L., et al. (Eds.), Virus Taxonomy: Classification and nomenclature of viruses. Seventh report of the International Committee on Taxonomy of Viruses. Academic Press, San Diego, pp. 835-849.
[11]	Schoeman, D., and Fielding, B.C., 2019. Coronavirus envelope protein: current knowledge. Virol. J. 16, 69.
[12]	Xue, X., Yu, H., Yang, H., Xue, F., Wu, Z., Shen, W., Li, J., Zhou, Z., Ding, Y., Zhao, Q., Zhang, X.C., Liao, M., Bartlam, M., and Rao, Z., 2008. Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design. J. Virol. 82, 2515-2527.
[13]	Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G.F., and Tan, W., 2020. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. DOI: 10.1056/NEJMoa2001017.